Free Content Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome

Authors: Voirin, N; Routy, J-P1; Smith, D2; Baratin, D3; Trépo, C; Cotte, L; Touraine, J-L4; Livrozet, J-M4; Cooper, DA2; Ritter, J; André, P; Vanhems, P

Source: HIV Medicine, Volume 9, Number 6, July 2008 , pp. 440-444(5)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Objectives

The effect of starting highly active antiretroviral therapy (HAART) early after the onset of acute retroviral syndrome (ARS) on CD4 and HIV-RNA trends was studied over a 2-year follow-up period. Methods

Four groups of HIV-infected patients stratified according to the time interval from ARS onset to HAART initiation and a control group of untreated patients were compared. Results

The results indicated that the earlier the start of HAART, the faster was the rate of CD4 increase and HIV-RNA decrease. However, this difference did not seem to persist at 24 months. Conclusions

The optimal treatment strategy for HIV-infected patients needs to be explored further.

Keywords: acute disease; CD4 lymphocyte count; highly active antiretroviral therapy; HIV infections; viral load

Document Type: Short communication

DOI: http://dx.doi.org/10.1111/j.1468-1293.2008.00576.x

Affiliations: 1: Immunodeficiency Service and Division of Hematology, McGill University Health Centre, Montreal, Quebec, Canada, 2: National Centre in HIV Epidemiology and Clinical Research, New South Wales University, Sydney, Australia, 3: Department of Hygiene, Epidemiology and Prevention, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France, 4: Transplantation and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France and

Publication date: 2008-07-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page